Literature DB >> 11712746

Interleukin-8 receptor antagonists in pulmonary diseases.

D W Hay1, H M Sarau.   

Abstract

Inflammatory cells are thought to be instrumental in the pathophysiology of pulmonary diseases, and control of their recruitment and activation in the lung would appear to be an attractive strategy for therapeutic intervention. Interleukin-8 and related CXC chemokines are involved in the function of neutrophils and T cells, and have been implicated in several lung diseases. Small-molecule antagonists of the interleukin-8 receptors have been identified, which may help elucidate the role of interleukin-8 and related chemokines in the pathophysiology of lung diseases.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11712746     DOI： 10.1016/s1471-4892(01)00043-1

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN： 1471-4892            Impact factor:   5.547


  14 in total

Review 1.  Chronic obstructive pulmonary disease * 12: New treatments for COPD.

Authors:  P J Barnes
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

2.  Effects of volatile vs. propofol-based intravenous anesthetics on the alveolar inflammatory responses to one-lung ventilation: a meta-analysis of randomized controlled trials.

Authors:  Bin Sun; Jinfeng Wang; Lulong Bo; Yan Zang; Haihui Gu; Jinbao Li; Baohua Qian
Journal:  J Anesth       Date:  2015-02-26       Impact factor: 2.078

3.  Picfeltarraenin IA inhibits lipopolysaccharide-induced inflammatory cytokine production by the nuclear factor-κB pathway in human pulmonary epithelial A549 cells.

Authors:  Rong Shi; Qing Wang; Yang Ouyang; Qian Wang; Xudong Xiong
Journal:  Oncol Lett       Date:  2015-12-16       Impact factor: 2.967

4.  Acute induction of human IL-8 production by intestinal epithelium triggers neutrophil infiltration without mucosal injury.

Authors:  T Kucharzik; J T Hudson; A Lügering; J A Abbas; M Bettini; J G Lake; M E Evans; T R Ziegler; D Merlin; J L Madara; I R Williams
Journal:  Gut       Date:  2005-06-29       Impact factor: 23.059

Review 5.  The cytokine network in asthma and chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

6.  IL-8 signaling does not mediate intra-amniotic LPS-induced inflammation and maturation in preterm fetal lamb lung.

Authors:  Suhas G Kallapur; Timothy J M Moss; Richard L Auten; Ilias Nitsos; J Jane Pillow; Boris W Kramer; Dean Y Maeda; John P Newnham; Machiko Ikegami; Alan H Jobe
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-02       Impact factor: 5.464

Review 7.  Therapy for chronic obstructive pulmonary disease in the 21st century.

Authors:  Louise E Donnelly; Duncan F Rogers
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  High Mobility Group Box-1 mediates hyperoxia-induced impairment of Pseudomonas aeruginosa clearance and inflammatory lung injury in mice.

Authors:  Vivek S Patel; Ravikumar A Sitapara; Ashwini Gore; Binh Phan; Lokesh Sharma; Vaishali Sampat; Jian Hua Li; Huan Yang; Sangeeta S Chavan; Haichao Wang; Kevin J Tracey; Lin L Mantell
Journal:  Am J Respir Cell Mol Biol       Date:  2012-10-18       Impact factor: 6.914

Review 9.  Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease.

Authors:  Nikolaos M Siafakas; Katerina M Antoniou; Eleni G Tzortzaki
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 10.  Pathophysiological roles of microvascular alterations in pulmonary inflammatory diseases: possible implications of tumor necrosis factor-alpha and CXC chemokines.

Authors:  Kanami Orihara; Akio Matsuda
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.